Literature DB >> 15539963

Intensive lifestyle modification: impact on cardiovascular disease risk factors in subjects with and without clinical cardiovascular disease.

Darrell L Ellsworth1, Sean C O'Dowd, Barbara Salami, Alan Hochberg, Marina N Vernalis, Debra Marshall, Jonathan A Morris, Richard I Somiari.   

Abstract

Intensive lifestyle modification programs are intended to stabilize or promote regression of coronary artery disease; however, clinical response is often nonuniform, complicating appropriate utilization of resources and prediction of outcome. This study assessed physiological and psychological benefits to 72 persons participating in a prospective, nonrandomized, four-component lifestyle change program and compared response between patients with clinical cardiovascular disease (CVD) and patients with elevated risk factors for CVD but without clinical manifestations of disease. Subjects entering the program due to elevated risk factor levels alone demonstrated equal or greater benefit, in terms of improvement in primary CVD risk factors and reduction in measures of coronary disease risk developed in the Framingham Heart Study, than those with clinical CVD. These findings suggest that intensive lifestyle change programs may be important for primary prevention in individuals at increased risk of CVD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539963     DOI: 10.1111/j.1520-037x.2004.3332.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  7 in total

1.  Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy.

Authors:  David J Decewicz; David M Neatrour; Amy Burke; Mary Jane Haberkorn; Heather L Patney; Marina N Vernalis; Darrell L Ellsworth
Journal:  Lipids Health Dis       Date:  2009-06-29       Impact factor: 3.876

2.  Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial.

Authors:  Nisa M Maruthur; Nae-Yuh Wang; Lawrence J Appel
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690

3.  Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.

Authors:  Gail L Daumit; Donald C Goff; Jonathan M Meyer; Vicki G Davis; Henry A Nasrallah; Joseph P McEvoy; Robert Rosenheck; Sonia M Davis; John K Hsiao; T Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2008-09-04       Impact factor: 4.939

4.  Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study.

Authors:  Ersen B Colkesen; Bart S Ferket; Jan G P Tijssen; Roderik A Kraaijenhagen; Coenraad K van Kalken; Ron J G Peters
Journal:  Vasc Health Risk Manag       Date:  2011-02-09

5.  Gene expression profiling during intensive cardiovascular lifestyle modification: Relationships with vascular function and weight loss.

Authors:  Heather L Blackburn; Seóna McErlean; Gera L Jellema; Ryan van Laar; Marina N Vernalis; Darrell L Ellsworth
Journal:  Genom Data       Date:  2015-03-12

6.  Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review.

Authors:  David Stevens; Deirdre A Lane; Stephanie L Harrison; Gregory Y H Lip; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2021-12-18       Impact factor: 4.615

7.  Evaluation of a community intervention program in Japan using Framingham risk score and estimated 10-year coronary heart disease risk as outcome variables: a non-randomized controlled trial.

Authors:  Bing Zhu; Yasuo Haruyama; Takashi Muto; Akiko Yamasaki; Fumiko Tarumi
Journal:  BMC Public Health       Date:  2013-03-11       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.